This article was originally posted on August 27, when we first saw these ads circulating… apparently lots of folks missed it, and the ads are running hot and heavy again, so we’re re-posting it here to help answer a flood of new reader questions. The stock teased has popped 40-50% or so on the Stansberry […]
Articles
I got several reader questions this week about a new recommendation from Dave Lashmet at Stansberry — it looks like this was issued as a recommendation for regular Stansberry Investment Advisory subscribers, not one of Lashmet’s more expensive biotech-focused newsletters, and it’s very light on clues… but let’s see if we can give you anything […]
Dave Lashmet has been a biotech/medical analyst and sometimes a newsletter editor at Stansberry for a long time, and the latest iteration of his high-end newsletter is now called Stansberry Venture Technology (currently “on sale” for $2,500, no refunds)… and it’s now being promoted with a “cure for cancer” spiel, so we obviously all want […]
The ads that get the most attention tend to be either those that are most dramatically distributed, with seemingly every single email address getting multiple copies… or those that come with a big promise and a very high price. Today’s topic of interest is the latter, since we’re told that Stansberry Venture Value’s Dave Lashmet […]
Lots and lots and lots of you have been asking me about the big “cancer presentation” that the Stansberry folks made last night, which apparently was a combination of Dr. David Eifrig’s medical advice and forecasting and Dave Lashmet’s hinting about his “medical breakthrough” stock… so let’s get to it. I did not watch or […]
Alzheimer’s Disease always gets a lot of attention from newsletter publishers, readers and investors — not only because we all know someone who suffers from this terrible malady, but because we know that the current treatments are ineffective and the market is huge… which means that any real solutions or more effective treatments could create […]
Dave Lashmet is sending around an ad for his Stansberry Venture service that he says highlights an investment that is “Three Times Better Than Any Opportunity I’ve Ever Found.” So that sounds pretty good, right? One nice thing about being an investment chatterer is that you can have a short memory — each idea that […]
Dave Lashmet has teased a handful of biotech stocks since starting the Stansberry Venture service a couple years ago, and they usually get a lot of attention from our readers — so the new ad from Lashmet today has been forwarded to me dozens of times already. And while I’m not sure we’ll be able […]
Stansberry Venture is a high-end ($5,000/yr) newsletter that focuses on small “breakthrough” type companies, so far mostly in biotech and technology as far as I’ve seen. It’s the heir, roughly speaking, of Stansberry’s old Phase 1 newsletter that used to often pitch biotech, tech and junior mining stocks. It’s helmed by Dave Lashmet, who was […]
That’s a mysterious headline, right? The pitch we’re looking at today is from Dave Lashmet at Stansberry, who’s selling his Stansberry Venture newsletter for $5,000 — and the carrot he’s dangling to get you to subscribe is this “most disruptive biotech discovery” … which, it turns out, is a form of radiation therapy that, in […]
We’ve got a good teaser to solve today, but first — a quick plea: This will be our final week of “Gumshoe Gives Back” this year — we will be donating at least half of all the membership contributions received through the rest of this week (until the end of the day on Friday, 12/12) […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
i has spend time back testing JB's webinar for the timed stock. non of the stocks he mentioned in the talk was verifia...
I looked at the chart that is shown during his presentation when he references the July 30th target, and it matches Homo...
Notice that Jeff Brown is now trading under Brownstone Research not Bonner and Partners .....
Latest News by Jeff Brown, “FDA Fast Tracks $6.8 Billion Miracle Antibiotic for July Approval One microcap owns the ...
Hi, regarding another 9:30AM today... “ What I witnessed in Cambridge” “I saw something I wasn’t supposed to ...
Jeff Brown is claiming a #1 timed stock this week. Anyone know which biotech it is? I know in another discussion from Ja...
Any idea what Jeff Brown’s 3 picks for small IPO’s might be?...
Travis- what’s Jeff Browns ipo 2020 speech about ? This “penny stock” is gonna blow up to $48 .... what do you thi...
Thanks Travis. I do know that such a pitch is a trap to buy an investment letter but thanks to Stock Gumshoe we can get...
Those deadlines are often heavily exaggerated, and sometimes just completely made up -- they're more about getting you t...
Yes, it is SPRO , which stock has shot up the past 2 days....
For the 5G boom, Jeff outlines these - AKTS, LITE, IIVI, MTSI For AI, he outlines - AMBA, YEXT...
I just joined Jeff Brown's service, shelled out $2k and purchased several of his recommended stocks - EDIT, CRSP, NTLA, ...
I am looking at this thread after hearing Jeff Brown's webinar promoting his expensive newsletter for $2000. Today, is A...
I assume you mean Jeff Brown, no? Not Jeff Bezos (of Amazon)? Brown has indeed been touting Editas for a long time...
That’s right! That’s what I have too but where do you get that? Is it a Federal government report or is it a stock m...
He has touted a great many 5G stocks over the past year, including NOK and SWKS and some of the little filter companies ...
Yes, Michael Robinson and Jeff Brown have both heavily teased NOK (and some other names) for their lower-cost newsletter...
Hey Travis, I really enjoy GUMSHOE I can get all the information from here. I bought some (CRON) but after I saw it wasn...
Jeff brown is pushing the Amazon coin and also the two blockchain sockets again right now dec 18....
STAY AWAY FROM Jeff Brown AND BONNER AND PARTNERS. THEY ARE CROOKS. I have purchased shares of EVERY one of the Companie...
The $6 stock that Jeff Brown is saying will form the infrastructure to create trillions isn't QCOM but is more likely NO...
November 7 - I just watched a webinar with the humorless Jeff Brown of Bonner. I feel so foolish as they promise Jeff w...
I watch Jeff Brown the other night 3 times give the same speech. all the time he is saying and I am going to give that s...
What about the $6 Digital King touted by "The Near Future Report" editor, Jeff Brown. He is claiming the new technology...
Wanda did you buy the $74 jeff brown report? What about his stock tips any good? ?is this a scam or worth the money...
Have any of you researched the potential cost of one of these treatments. I'd guess in the hundreds of thousands per pa...
Has the "shoe" figured out what $0.13 Tech Stock-is a no brainer from Jeff Brown this week?...
I watched Jeff Brown's pitch on crypto currency in the rest of his topics. I really believe he is full of crap because I...
Jeff Brown from Bonner & Partners is also selling information on biotech companies who are about to release trial re...
JEFF BROWN IS VERY CONFUSING TO FOLLOW HE IS AGAINST WHAT HE IS FOR....AND VICE VERSA.......
Have you had any requests to find out what Jeff Brown is touting for Bonner. He says he has two companies tied to crypto...
I would like to to see Jeff Brown and others pitch a new tech company, not regurgitate old ones. They're all the same. ...
I think this is about the Jeff Brown tease -- we covered that here: https://www.stockgumshoe.com/reviews/near-future-rep...
Mining rigs and blockchain node servers don’t use a ton of DRAM, but they must use solid state drives, made from NAND ...
I wrote about a different Jeff Brown pitch recently, but haven't seen him hint at any blockchain investments of late -- ...
Ok I'll admit it...I love to gamble. Jeff brown sounded like a snake oil dealer and i'm probably not wrong. I'm not real...
I realize this thread is well over a year old, but it looked like the best place to plug in to the topic of driverless c...
A bill Bonner Jeff Brown? investment letter...
Gene hacking stock commented by Jeff Brown is Editas medicine...